10 20 30 40 50 60 70 80 3HOK - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER OXIDOREDUCTASE 02-JUN-09 3HOK
TITLE X-RAY CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 WITH (2R, TITLE 2 4S)-2-[2-(4-CHLOROPHENYL)ETHYL]-2-[(1H-IMIDAZOL-1-YL) TITLE 3 METHYL]-4[((5-TRIFLUOROMETHYLPYRIDIN-2-YL)THIO)METHYL]-1,3- TITLE 4 DIOXOLANE: A NOVEL, INDUCIBLE BINDING MODE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEME OXYGENASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 1-233; COMPND 5 SYNONYM: HO-1; COMPND 6 EC: 1.14.99.3; COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HMOX1, HO, HO1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5-ALPHA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: DELTA 233-HHO-1
KEYWDS PROTEIN-INHIBITOR COMPLEX, ALPHA HELICES, ENDOPLASMIC KEYWDS 2 RETICULUM, HEME, IRON, METAL-BINDING, MICROSOME, KEYWDS 3 OXIDOREDUCTASE, PHOSPHOPROTEIN, POLYMORPHISM
EXPDTA X-RAY DIFFRACTION
AUTHOR M.N.RAHMAN,Z.JIA
REVDAT 2 13-OCT-09 3HOK 1 JRNL REVDAT 1 28-JUL-09 3HOK 0
JRNL AUTH M.N.RAHMAN,J.Z.VLAHAKIS,D.VUKOMANOVIC,W.A.SZAREK, JRNL AUTH 2 K.NAKATSU,Z.JIA JRNL TITL X-RAY CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 JRNL TITL 2 WITH (2R,4S)-2-[2-(4-CHLOROPHENYL)ETHYL]-2-[(1H- JRNL TITL 3 IMIDAZOL-1-YL)METHYL]-4[((5-TRIFLUOROMETHYLPYRIDIN- JRNL TITL 4 2-YL)THIO)METHYL]-1,3-DIOXOLANE: A NOVEL, INDUCIBLE JRNL TITL 5 BINDING MODE. JRNL REF J.MED.CHEM. V. 52 4946 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19601578 JRNL DOI 10.1021/JM900434F
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0069 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 88.4 REMARK 3 NUMBER OF REFLECTIONS : 18614 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1018 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.24 REMARK 3 REFLECTION IN BIN (WORKING SET) : 799 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 52.40 REMARK 3 BIN R VALUE (WORKING SET) : 0.2340 REMARK 3 BIN FREE R VALUE SET COUNT : 41 REMARK 3 BIN FREE R VALUE : 0.3290 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3498 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 118 REMARK 3 SOLVENT ATOMS : 186 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.78000 REMARK 3 B22 (A**2) : -3.33000 REMARK 3 B33 (A**2) : 0.32000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.38000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.544 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.303 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.218 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.412 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.881 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3715 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5053 ; 1.047 ; 2.046 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 427 ; 5.394 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 180 ;33.112 ;23.889 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 637 ;18.076 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;19.000 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 527 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2839 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2147 ; 0.504 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3457 ; 0.934 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1568 ; 1.124 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1596 ; 1.883 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS
REMARK 4 REMARK 4 3HOK COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JUN-09. REMARK 100 THE RCSB ID CODE IS RCSB053388.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9789 REMARK 200 MONOCHROMATOR : HORIZONTAL FOCUSING 5.05 REMARK 200 ASYMMETRIC CUT SI(111) REMARK 200 OPTICS : BENT TRIANGULAR ASYMMETRIC REMARK 200 CUT SI(111) MONOCHROMATER REMARK 200 PROVIDES HORIZONTAL FOCUSING. REMARK 200 RH-COATED SI MIRROR FOR REMARK 200 VERTICAL FOCUSING. REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19633 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.9 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : 0.09800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.3100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 68.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.35500 REMARK 200 R SYM FOR SHELL (I) : 0.35500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.371 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1N3U REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.16 M AMMONIUM SULFATE, 1.15% 1,6- REMARK 280 HEXANEDIOL, 0.1 M HEPES, PH 7.25, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 295K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.29600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ARG A 3 REMARK 465 PRO A 4 REMARK 465 GLN A 5 REMARK 465 PRO A 6 REMARK 465 ASP A 7 REMARK 465 SER A 8 REMARK 465 MET A 9 REMARK 465 ASP A 224 REMARK 465 THR A 225 REMARK 465 LYS A 226 REMARK 465 ASP A 227 REMARK 465 GLN A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 SER A 231 REMARK 465 ARG A 232 REMARK 465 ALA A 233 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 ARG B 3 REMARK 465 PRO B 4 REMARK 465 GLN B 5 REMARK 465 PRO B 6 REMARK 465 ASP B 7 REMARK 465 SER B 8 REMARK 465 ASP B 224 REMARK 465 THR B 225 REMARK 465 LYS B 226 REMARK 465 ASP B 227 REMARK 465 GLN B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 SER B 231 REMARK 465 ARG B 232 REMARK 465 ALA B 233
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 21 13.27 -65.25 REMARK 500 ARG A 35 -42.56 169.41 REMARK 500 GLN A 38 -38.95 -130.56 REMARK 500 LYS A 39 -1.59 -55.74 REMARK 500 GLN A 41 42.68 -162.27 REMARK 500 GLU A 70 -24.70 96.56 REMARK 500 ARG A 113 -70.75 -41.69 REMARK 500 ARG A 136 -73.73 -68.37 REMARK 500 GLN A 145 -76.01 -96.50 REMARK 500 ALA A 151 -98.83 -51.81 REMARK 500 GLN A 152 -72.14 -30.47 REMARK 500 LEU A 155 -142.81 -129.62 REMARK 500 ASP A 156 -140.56 -88.73 REMARK 500 PRO A 158 167.40 -48.29 REMARK 500 SER A 159 53.88 -62.66 REMARK 500 GLN B 41 -79.39 -46.79 REMARK 500 VAL B 42 127.33 154.87 REMARK 500 GLU B 70 -29.85 93.73 REMARK 500 PHE B 74 -43.54 -131.16 REMARK 500 ALA B 75 -60.82 -24.55 REMARK 500 HIS B 84 124.30 -31.66 REMARK 500 ASP B 156 70.47 12.05 REMARK 500 PRO B 158 -171.53 -68.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 156 LEU A 157 33.88 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 249 DISTANCE = 5.31 ANGSTROMS REMARK 525 HOH A 258 DISTANCE = 6.10 ANGSTROMS REMARK 525 HOH B 271 DISTANCE = 5.01 ANGSTROMS REMARK 525 HOH A 305 DISTANCE = 5.32 ANGSTROMS REMARK 525 HOH B 314 DISTANCE = 5.70 ANGSTROMS REMARK 525 HOH A 325 DISTANCE = 7.77 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 300 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 300 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Q80 B 301
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CZY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 IN COMPLEX WITH REMARK 900 1-(ADAMANTAN-1-YL)-2-(1H-IMIDAZOL-1-YL)ETHANONE REMARK 900 RELATED ID: 1N45 RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 (HO-1) IN REMARK 900 COMPLEX WITH ITS SUBSTRATE HEME
DBREF 3HOK A 1 233 UNP P09601 HMOX1_HUMAN 1 233 DBREF 3HOK B 1 233 UNP P09601 HMOX1_HUMAN 1 233
SEQRES 1 A 233 MET GLU ARG PRO GLN PRO ASP SER MET PRO GLN ASP LEU SEQRES 2 A 233 SER GLU ALA LEU LYS GLU ALA THR LYS GLU VAL HIS THR SEQRES 3 A 233 GLN ALA GLU ASN ALA GLU PHE MET ARG ASN PHE GLN LYS SEQRES 4 A 233 GLY GLN VAL THR ARG ASP GLY PHE LYS LEU VAL MET ALA SEQRES 5 A 233 SER LEU TYR HIS ILE TYR VAL ALA LEU GLU GLU GLU ILE SEQRES 6 A 233 GLU ARG ASN LYS GLU SER PRO VAL PHE ALA PRO VAL TYR SEQRES 7 A 233 PHE PRO GLU GLU LEU HIS ARG LYS ALA ALA LEU GLU GLN SEQRES 8 A 233 ASP LEU ALA PHE TRP TYR GLY PRO ARG TRP GLN GLU VAL SEQRES 9 A 233 ILE PRO TYR THR PRO ALA MET GLN ARG TYR VAL LYS ARG SEQRES 10 A 233 LEU HIS GLU VAL GLY ARG THR GLU PRO GLU LEU LEU VAL SEQRES 11 A 233 ALA HIS ALA TYR THR ARG TYR LEU GLY ASP LEU SER GLY SEQRES 12 A 233 GLY GLN VAL LEU LYS LYS ILE ALA GLN LYS ALA LEU ASP SEQRES 13 A 233 LEU PRO SER SER GLY GLU GLY LEU ALA PHE PHE THR PHE SEQRES 14 A 233 PRO ASN ILE ALA SER ALA THR LYS PHE LYS GLN LEU TYR SEQRES 15 A 233 ARG SER ARG MET ASN SER LEU GLU MET THR PRO ALA VAL SEQRES 16 A 233 ARG GLN ARG VAL ILE GLU GLU ALA LYS THR ALA PHE LEU SEQRES 17 A 233 LEU ASN ILE GLN LEU PHE GLU GLU LEU GLN GLU LEU LEU SEQRES 18 A 233 THR HIS ASP THR LYS ASP GLN SER PRO SER ARG ALA SEQRES 1 B 233 MET GLU ARG PRO GLN PRO ASP SER MET PRO GLN ASP LEU SEQRES 2 B 233 SER GLU ALA LEU LYS GLU ALA THR LYS GLU VAL HIS THR SEQRES 3 B 233 GLN ALA GLU ASN ALA GLU PHE MET ARG ASN PHE GLN LYS SEQRES 4 B 233 GLY GLN VAL THR ARG ASP GLY PHE LYS LEU VAL MET ALA SEQRES 5 B 233 SER LEU TYR HIS ILE TYR VAL ALA LEU GLU GLU GLU ILE SEQRES 6 B 233 GLU ARG ASN LYS GLU SER PRO VAL PHE ALA PRO VAL TYR SEQRES 7 B 233 PHE PRO GLU GLU LEU HIS ARG LYS ALA ALA LEU GLU GLN SEQRES 8 B 233 ASP LEU ALA PHE TRP TYR GLY PRO ARG TRP GLN GLU VAL SEQRES 9 B 233 ILE PRO TYR THR PRO ALA MET GLN ARG TYR VAL LYS ARG SEQRES 10 B 233 LEU HIS GLU VAL GLY ARG THR GLU PRO GLU LEU LEU VAL SEQRES 11 B 233 ALA HIS ALA TYR THR ARG TYR LEU GLY ASP LEU SER GLY SEQRES 12 B 233 GLY GLN VAL LEU LYS LYS ILE ALA GLN LYS ALA LEU ASP SEQRES 13 B 233 LEU PRO SER SER GLY GLU GLY LEU ALA PHE PHE THR PHE SEQRES 14 B 233 PRO ASN ILE ALA SER ALA THR LYS PHE LYS GLN LEU TYR SEQRES 15 B 233 ARG SER ARG MET ASN SER LEU GLU MET THR PRO ALA VAL SEQRES 16 B 233 ARG GLN ARG VAL ILE GLU GLU ALA LYS THR ALA PHE LEU SEQRES 17 B 233 LEU ASN ILE GLN LEU PHE GLU GLU LEU GLN GLU LEU LEU SEQRES 18 B 233 THR HIS ASP THR LYS ASP GLN SER PRO SER ARG ALA
HET HEM A 300 43 HET HEM B 300 43 HET Q80 B 301 32
HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM Q80 2-({[(2R,4S)-2-[2-(4-CHLOROPHENYL)ETHYL]-2-(1H- HETNAM 2 Q80 IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4- HETNAM 3 Q80 YL]METHYL}SULFANYL)-5-(TRIFLUOROMETHYL)PYRIDINE
HETSYN HEM HEME
FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 5 Q80 C22 H21 CL F3 N3 O2 S FORMUL 6 HOH *186(H2 O)
HELIX 1 1 ASP A 12 THR A 21 1 10 HELIX 2 2 THR A 21 ALA A 31 1 11 HELIX 3 3 GLU A 32 PHE A 37 1 6 HELIX 4 4 THR A 43 LYS A 69 1 27 HELIX 5 5 PHE A 74 TYR A 78 5 5 HELIX 6 6 PHE A 79 HIS A 84 1 6 HELIX 7 7 ARG A 85 GLY A 98 1 14 HELIX 8 8 ARG A 100 ILE A 105 1 6 HELIX 9 9 THR A 108 GLU A 125 1 18 HELIX 10 10 LEU A 128 GLY A 144 1 17 HELIX 11 11 GLN A 145 ALA A 154 1 10 HELIX 12 12 LEU A 164 THR A 168 5 5 HELIX 13 13 SER A 174 ASN A 187 1 14 HELIX 14 14 THR A 192 LEU A 221 1 30 HELIX 15 15 ASP B 12 THR B 21 1 10 HELIX 16 16 THR B 21 LYS B 39 1 19 HELIX 17 17 THR B 43 LYS B 69 1 27 HELIX 18 18 PHE B 74 TYR B 78 5 5 HELIX 19 19 PHE B 79 HIS B 84 1 6 HELIX 20 20 ARG B 85 TYR B 97 1 13 HELIX 21 21 ARG B 100 ILE B 105 1 6 HELIX 22 22 THR B 108 GLU B 125 1 18 HELIX 23 23 LEU B 128 LEU B 155 1 28 HELIX 24 24 LEU B 164 THR B 168 5 5 HELIX 25 25 SER B 174 ASN B 187 1 14 HELIX 26 26 THR B 192 LEU B 221 1 30
LINK NE2 HIS A 25 FE HEM A 300 1555 1555 2.28 LINK NE2 HIS B 25 FE HEM B 300 1555 1555 2.24
SITE 1 AC1 13 HIS A 25 ALA A 28 GLU A 29 TYR A 134 SITE 2 AC1 13 THR A 135 GLY A 139 SER A 142 ARG A 183 SITE 3 AC1 13 PHE A 207 ASN A 210 PHE A 214 HOH A 323 SITE 4 AC1 13 HOH A 332 SITE 1 AC2 14 LYS B 18 HIS B 25 ALA B 28 GLU B 29 SITE 2 AC2 14 GLU B 32 TYR B 134 THR B 135 LEU B 138 SITE 3 AC2 14 GLY B 139 SER B 142 ARG B 183 PHE B 207 SITE 4 AC2 14 ASN B 210 Q80 B 301 SITE 1 AC3 11 ALA B 31 ARG B 35 VAL B 50 GLY B 139 SITE 2 AC3 11 ASP B 140 GLY B 143 LEU B 147 PHE B 167 SITE 3 AC3 11 PHE B 214 GLU B 215 HEM B 300
CRYST1 55.072 54.592 71.884 90.00 94.64 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018158 0.000000 0.001474 0.00000
SCALE2 0.000000 0.018318 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013957 0.00000